Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Appointed director
|
QSAM Biosciences, Inc. (QSAM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/28/2022 |
8-K
| Appointed a new director
Docs:
|
"Independent Director Compensation",
"QSAM Biosciences Appoints Adriann Sax to Board of Directors Austin, TX; January 25, 2022 – QSAM Biosciences Inc . , a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP , for the treatment of cancer and related diseases, today announces the appointment of Adriann Sax to the QSAM Biosciences Board of Directors. Ms. Sax will serve on the Company’ s Audit Committee and will chair the Nomination and Governance Committee. Ms. Sax has a distinguished 30+ year career in biotech and life sciences, serving in leadership, operational and business development roles with a focus on oncology for both Fortune 100 and start-up companies. She currently serves as CEO and co-founder of Vetigenics LLC, an animal health biotech company, where she has secured part..." |
|
01/17/2020 |
8-K
| Appointed a new director |
08/01/2008 |
8-K
| Form 8-K - Current report |
|
|